120 related articles for article (PubMed ID: 38843120)
41. Effect of micro-environment modification and polymer type on the in-vitro dissolution behavior and in-vivo performance of amorphous solid dispersions.
Sun W; Pan B
Eur J Pharm Sci; 2017 Jun; 104():240-254. PubMed ID: 28412483
[TBL] [Abstract][Full Text] [Related]
42. Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation.
Leng D; Bulduk B; Anlahr J; Müllers W; Löbmann K
Int J Pharm; 2023 Mar; 635():122693. PubMed ID: 36754186
[TBL] [Abstract][Full Text] [Related]
43. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
44. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
[TBL] [Abstract][Full Text] [Related]
45. The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil.
Ertürk AS; Gürbüz MU; Tülü M
Pharm Dev Technol; 2017 Feb; 22(1):111-121. PubMed ID: 27484586
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
Feng J; Xu L; Gao R; Luo Y; Tang X
Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
[TBL] [Abstract][Full Text] [Related]
47. Comparative assessment of solubility enhancement of itroconazole by solid dispersion and co-crystallization technique: Investigation of simultaneous effect of media composition on drug dissolution.
Rajbhar K; Karodadeo GR; Kumar V; Barethiya V; Lahane A; Kale S; Thakre V; Dixit G; Kohale N; Hiradeve S; Rarokar NR
Ann Pharm Fr; 2023 Sep; 81(5):843-855. PubMed ID: 37182590
[TBL] [Abstract][Full Text] [Related]
48. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
Prasad D; Chauhan H; Atef E
Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
[TBL] [Abstract][Full Text] [Related]
49. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
Yuvaraja K; Khanam J
J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
[TBL] [Abstract][Full Text] [Related]
50. Solubilization of the poorly water soluble drug, telmisartan, using supercritical anti-solvent (SAS) process.
Park J; Cho W; Cha KH; Ahn J; Han K; Hwang SJ
Int J Pharm; 2013 Jan; 441(1-2):50-5. PubMed ID: 23262425
[TBL] [Abstract][Full Text] [Related]
51. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
[TBL] [Abstract][Full Text] [Related]
52. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
Ojo AT; Ma C; Lee PI
Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
[TBL] [Abstract][Full Text] [Related]
53. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
54. Cefdinir Solid Dispersion Composed of Hydrophilic Polymers with Enhanced Solubility, Dissolution, and Bioavailability in Rats.
Cho HJ; Jee JP; Kang JY; Shin DY; Choi HG; Maeng HJ; Cho KH
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208830
[TBL] [Abstract][Full Text] [Related]
55. Design of mirtazapine solid dispersion with different carriers' systems: optimization, in vitro evaluation, and bioavailability assessment.
Aldeeb RAE; Mahdy MAE; El-Nahas HM; Musallam AA
Drug Deliv Transl Res; 2023 Sep; 13(9):2340-2352. PubMed ID: 36940079
[TBL] [Abstract][Full Text] [Related]
56. Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System.
de Campos DP; Silva-Barcellos NM; Lima RR; Savedra RML; Siqueira MF; Yoshida MI; da Nova Mussel W; de Souza J
AAPS PharmSciTech; 2018 Oct; 19(7):3019-3028. PubMed ID: 30062540
[TBL] [Abstract][Full Text] [Related]
57. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
58. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
Gao F; Zhang Z; Bu H; Huang Y; Gao Z; Shen J; Zhao C; Li Y
J Control Release; 2011 Jan; 149(2):168-74. PubMed ID: 20951749
[TBL] [Abstract][Full Text] [Related]
59. Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions.
Chen C; Xie X; Li Y; Zhou C; Song Y; Yan Z; Yang X
Drug Dev Ind Pharm; 2014 Apr; 40(4):441-51. PubMed ID: 23614831
[TBL] [Abstract][Full Text] [Related]
60. Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility.
Hirlekar RS; Sonawane SN; Kadam VJ
AAPS PharmSciTech; 2009; 10(3):858-63. PubMed ID: 19562489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
